Peter Dolan
Peter Dolan
Peter R. Dolanis an American business executive. In 2009, he became Chairman and CEO of Gemin X Pharmaceuticals after joining board in July 2008, he was formerly the chief executive officer of Bristol-Myers Squibb before being discharged from that company in September 2006 as a result of a federal investigation into questions concerning the patent of drug Plavix...
history pipeline promising shape taking
We see a promising pipeline taking shape - one of the most promising pipelines in our company's history.
based board bringing meeting next present raising together town
I've put together a proposal, based on negotiations with Metro-North, that I'll present at our next Town Board meeting for raising our fees and bringing them in line.
add again billion billions challenge company create dollars double earnings five intended next per plan products pursue revenue several
This new plan is intended to challenge the company over the next five years to again double sales, earnings and earnings per share, to create 'mega-blockbuster' products of several billion dollars and to pursue 'mega-blockbuster ideas' that can also add billions of dollars in revenue growth,
behind current drive earnings efforts focused fund growth harder investing order pipeline resources revenue stay
For revenue and earnings growth to occur, we must stay focused on investing behind our pipeline and we must drive our current productivity efforts even harder in order to have the resources to fund those investments.
against agreement builds commitment fight global
This agreement builds on Bristol-Myers Squibb's long-standing commitment to the global fight against AIDS.
addressing against agreement aids approach builds commitment committing ensure fight global including medicines pandemic patents prevent prices profit providing taken treatment
This agreement builds on Bristol-Myers' long-standing commitment to the global fight against AIDS. In Sub-Saharan Africa, where the HIV/AIDS pandemic has been especially devastating, we've taken a broad-based approach to addressing the AIDS crisis, including providing our AIDS medicines at no profit prices and committing to ensure our patents do not prevent inexpensive treatment in the region.
businesses growing impressive key record track
Lamberto is an outstanding leader, with an impressive track record at Bristol-Myers Squibb of growing key franchises and businesses around the world,
absolute council safety treats
The council treats everyone's safety as an absolute priority.
a much better alternative to other alternatives that could have been considered.
beginning business frame modeled modest negative neutral positive slightly time
You could see in the beginning some modest positive benefit, but I think in a three-to-five-year time frame ... what we modeled into our business is (a) neutral to slightly negative impact,
behind causes community company continue enhancing expertise explore extending forward grateful greatly human leadership leave legacy life lived mission moves next past plans rely service six skills strategic tremendous truly vision wisdom
In his professional life as well as in his service to the community and other causes, he truly has lived our company mission of extending and enhancing human life, ... Don will leave behind a tremendous legacy of achievement. The company and I have benefited greatly from Don's strategic vision and outstanding organizational skills over the past years, and I'm grateful I will be able to continue to rely on his wisdom and expertise over the next six months, as he moves forward with his plans to explore new leadership opportunities ahead.
career leadership
Over his 24-year career with Bristol-Myers Squibb, Don has demonstrated extraordinary leadership on many different fronts,